Search - tctmd.com

Displaying 121 - 140 of 264

Sort: Relevancy | Date

Presentation TCT 2014

Percutaneous Coronary Intervention of Very Small Vessels in the RESOLUTE Global Clinical Program

Presenter: Antonio Serra

September 16, 2014

Presentation TCT 2014

Multi-Vessel Versus Single-Vessel Treatment with Resolute Zotarolimus Eluting Stent in the RESOLUTE Global Clinical Program

Presenter: Ganesh Manoharan

September 16, 2014

Presentation TCT 2014

Long-Term Clinical Outcomes For Primary Angioplasty with Resolute Zotarolimus Eluting Stent in ST-Segment Elevation Acute Myocardial Infarction

Presenter: Carlo Di Mario

September 16, 2014

Presentation TCT 2014

2-Year Clinical Outcome of the Randomized, Multicenter DUTCH PEERS (TWENTE II) Trial, Comparing Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Stents and Platinum-Chromi___

Presenter: Clemens von Birgelen

September 16, 2014

Presentation TCT 2014

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

Presenter: Milan Chag

September 16, 2014

News Conference News TCT 2014

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

September 15, 2014

News Conference News TCT 2014

CTO-IVUS Trial Supports IVUS Guidance for CTO PCI

September 14, 2014

News Daily News

PROTECT: Menor Riesgo de Trombosis del Stent con el Endeavor a los 4 Años

L.A. McKeown

September 02, 2014

News Daily News

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

L.A. McKeown

September 02, 2014

News Daily News

PROTECT： 4年时采用Endeavor情况下的支架内血栓形成风险更低

L.A. McKeown

September 02, 2014

News Conference News ESC 2014

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

Todd Neale

August 30, 2014

News Daily News

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

July 10, 2014

News Daily News

HOST-ASSURE: Promus Element No es Inferior al Resolute en una Población de Pacientes No Seleccionados

July 10, 2014

News Daily News

HOST-ASSURE：在一般人群中，Promus Element不比Resolute差

July 10, 2014

News Daily News

SCAAR: Menor Riesgo de Trombosis Precoz, Tardía del Stent con Nuevos SLF frente a SMD en el Manejo de Cuadros de STEMI

Yael L. Maxwell

July 03, 2014

News Daily News

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Yael L. Maxwell

July 03, 2014

News Industry News

Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study

May 29, 2014

News Conference News EuroPCR 2014

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Caitlin E. Cox

May 28, 2014

Presentation EuroPCR 2014

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

Presenter: Stephan Windecker

May 22, 2014

News Industry News

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patient

May 20, 2014

Advertisement

Percutaneous Coronary Intervention of Very Small Vessels in the RESOLUTE Global Clinical Program

Multi-Vessel Versus Single-Vessel Treatment with Resolute Zotarolimus Eluting Stent in the RESOLUTE Global Clinical Program

Long-Term Clinical Outcomes For Primary Angioplasty with Resolute Zotarolimus Eluting Stent in ST-Segment Elevation Acute Myocardial Infarction

2-Year Clinical Outcome of the Randomized, Multicenter DUTCH PEERS (TWENTE II) Trial, Comparing Cobalt-Chromium Zotarolimus-Eluting Resolute Integrity Stents and Platinum-Chromi___

Percutaneous Coronary Intervention of Small Vessels in the RESOLUTE Global Clinical Program: The Impact of Diabetes Mellitus

SECURITY: Six-Month DAPT Noninferior to 12 Months with Second-Generation DES

CTO-IVUS Trial Supports IVUS Guidance for CTO PCI

PROTECT: Menor Riesgo de Trombosis del Stent con el Endeavor a los 4 Años

PROTECT: Lower Stent Thrombosis Risk with Endeavor Emerges at 4 Years

PROTECT： 4年时采用Endeavor情况下的支架内血栓形成风险更低

SCAAR Confirms Low Very Late Stent Thrombosis Risk with Newer DES

HOST-ASSURE: Promus Element Noninferior to Resolute in All-Comers Population

HOST-ASSURE: Promus Element No es Inferior al Resolute en una Población de Pacientes No Seleccionados

HOST-ASSURE：在一般人群中，Promus Element不比Resolute差

SCAAR: Menor Riesgo de Trombosis Precoz, Tardía del Stent con Nuevos SLF frente a SMD en el Manejo de Cuadros de STEMI

SCAAR: Lower Risk of Early, Late Stent Thrombosis with Newer DES vs BMS in STEMI

Svelte Medical Systems Announces Completion of 6-Month Follow-up in the DIRECT II Drug-Eluting Stent Study

EuroPCR 2014: Clinical Challenges, Novel Innovations Share the Limelight

Final Five-year Outcomes from the Randomized Comparison of Zotarolimus-eluting Stents With Everolimus-eluting Stents in the RESOLUTE All Comers Trial

STENTYS Sirolimus-Eluting Stent Demonstrates Best in Class Efficacy for Heart Attack Patient

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content